ГЕНДЕРНЫЕ ОСОБЕННОСТИ ВЗАИМОСВЯЗИ МОЗГОВОГО НАТРИЙРЕТИЧЕСКОГО ПЕПТИДА СО СТРУКТУРНО-ФУНКЦИОНАЛЬНЫМИ ПАРАМЕТРАМИ СЕРДЦА В РАННЕМ ПОСТИНФАРКТНОМ ПЕРИОДЕ

Список литературы

• Melen Y.P. Effect of primary stenting of coronary arteries on clinical course and remodeling of the left ventricle in patients with acute st segment elevation myocardial infarction (results after 12 months) / Y.P. Melen, V.A. Skybchik, M.Y. Fedechko et al. // Wiad Lek. – 2020. – № 73(1). – P. 68-72.

• Venkatesan C. Outcomes trends for acute myocardial infarction, congestive heart failure, and pneumonia, 2005-2009 / C. Venkatesan, A. Mishra, A. Morgan et al. // Am J Manag Care. – 2016. – № 22(1). – P. 9-17.

• Tomoaia R. Understanding the role of echocardiography in remodeling after acute myocardial infarction and development of heart failure with preserved ejection fraction / R. Tomoaia, R.S. Beyer, G. Simu et al. // Med Ultrason. – 2019. – № 21(1). – P. 69-76.

• Ponikowski P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC / P. Ponikowski, A.A. Voors, S.D. Anker et al. // Eur. Heart J. – 2016. – № 37(27). – P. 2129-2200.

• Lee N.S. Current understanding of the compensatory actions of cardiac natriuretic peptides in cardiac failure: a clinical perspective / N.S. Lee, L.B. Daniels // Card. Fail. Rev. – 2016. – № 2(1). – P. 14-19.

• Nadir M.A. Myocardial ischaemia is associated with an elevated brain natriuretic pepide level even in the presence of left ventricular systolic dysfunction / M.A. Nadir, E. Dow, J. Davidson et al. // Eur J Heart Fail. – 2014. – № 16(1). – P.56-67.

• Tsai W. Multiple cardiac biomarkers used in clinical guideline for elderly patients with acute coronary syndrome / W. Tsai, D.K. Chien, C.H. Huang et al. // Int J of Gerontol. – 2017. – № 11(2). – P. 104-108.

• Morita E. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction / E. Morita, H. Yasue, M. Yoshimura // Circulation. – 1993. – № 88(1). – P. 82-91.

• Irzma R. Dynamics of changes of the BNP concentration in patients with stable angina pectoris qualified for PTCA. Dependence on the selected morphological and haemodynamic parameters / R. Irzma, M. Piechota, M. Barylski et al. // Archives of Medical Science. – 2006. – № 2(1). – P. 15-19.

• Lindholm D. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome / D. Lindholm, S.K. James, M. Bertilsson et al. // Clin Chem. – 2017. – № 63(2). – P. 573-584.

• Parenica J. Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients – Multiple biomarkers prospective cohort study / J. Parenica, P. Kala, M.G. Pavkova et al. // Int J Cardiol. – 2016. – № 15(211). – P. 96-104.

• Schellings D.A. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores / D.A. Schellings, A. Adiyaman, J.E. Dambrink et al. // Vasc Health Risk Manag. – 2016. – № 21(12). – P. 471-476.

• Mathbout M. NT-proBNP Level Predicts Extent of Myonecrosis and Clinical Adverse Outcomes in Patients with ST-Elevation Myocardial Infarction: A Pilot Study / M. Mathbout, A. Asfour, S. Leung et al. // Med Res Arch. – 2020. – №8(2). – P. 10.

• Gong X. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI / X. Gong, T. Zhang, S. Feng et al. // Ann Palliat Med. – 2021. – № 10(5). – P. 5231-5243.